RAFAEL
TABARES SEISDEDOS
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital de Clínicas de Porto Alegre
Porto Alegre, BrasilHospital de Clínicas de Porto Alegre-ko ikertzaileekin lankidetzan egindako argitalpenak (18)
2020
-
Peripheral oxidative stress markers in patients with bipolar disorder during euthymia and in siblings
Endocrine, Metabolic and Immune Disorders - Drug Targets, Vol. 20, Núm. 1, pp. 77-86
2018
2017
-
Child and adolescent health from 1990 to 2015: Findings from the global burden of diseases, injuries, and risk factors 2015 study
JAMA Pediatrics, Vol. 171, Núm. 6, pp. 573-592
-
Clinical staging and serum cytokines in bipolar patients during euthymia
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 77, pp. 194-201
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1345-1422
-
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1260-1344
-
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1211-1259
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1423-1459
2016
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet, Vol. 388, Núm. 10053, pp. 1659-1724
-
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet, Vol. 388, Núm. 10053, pp. 1603-1658
-
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet, Vol. 388, Núm. 10053, pp. 1545-1602
-
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet, Vol. 388, Núm. 10053, pp. 1459-1544
-
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
The Lancet, Vol. 388, Núm. 10053, pp. 1813-1850
2013
2011
-
Therapeutic use of omega-3 fatty acids in bipolar disorder
Expert Review of Neurotherapeutics, Vol. 11, Núm. 7, pp. 1029-1047
2008
-
Functional impairment and previous suicide attempts in bipolar disorder
Acta Neuropsychiatrica, Vol. 20, Núm. 6, pp. 300-306